Induction of exportin-5 expression during melanoma development supports the cellular behavior of human malignant

Corinna Anna Ott1, Lisa Linck1, Elisabeth Kremmer2

  • 1Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.

Oncotarget
|August 25, 2016
PubMed

Insights

Exportin-5 (XPO5) is over-expressed in melanoma, disrupting microRNA (miRNA) maturation. This aberrant XPO5 expression promotes melanoma cell survival, proliferation, and metastasis, contributing to cancer aggressiveness.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Melanoma Pathogenesis

Background:

  • MicroRNAs (miRNAs) regulate gene expression and are implicated in cancer development.
  • While miRNA processing enzymes are altered in melanoma, miRNA transport has not been studied.
  • Exportin-5 (XPO5) is a key transporter for pre-miRNAs.

Purpose of the Study:

  • To investigate the role of Exportin-5 (XPO5) in miRNA maturation and its functional consequences in melanoma.
  • To determine if XPO5 is mis-regulated in melanoma and contributes to malignant behavior.

Main Methods:

  • Quantification of XPO5 expression in melanoma versus melanocytes.
  • Analysis of XPO5 mRNA stability and regulation by MEK signaling.
  • XPO5 knockdown experiments in melanoma cell lines to assess effects on miRNA levels and cell function.

Main Results:

  • XPO5 is significantly over-expressed in melanoma compared to melanocytes.
  • Enhanced XPO5 mRNA stability contributes to elevated XPO5 protein levels, regulated by MEK signaling.
  • XPO5 knockdown reduced mature miRNA levels and impaired melanoma cell proliferation, survival, and metastasis.

Conclusions:

  • Aberrant XPO5 expression is crucial for miRNA maturation and the malignant phenotype of melanoma.
  • High XPO5 abundance in melanoma likely enhances cell survival, proliferation, and metastasis, driving cancer aggressiveness.
  • XPO5 represents a potential therapeutic target for melanoma treatment.